Effect of a Mobile Health Intervention on Treatment Adherence

Status Completed

Clinical Trial Summary

This is a randomized clinical trial across the whole of the patients who attend the HIV Unit of the Hospital Civil Viejo, a sample calculated in 43 patients for each group (intervention and control). Patients who have HIV infection and are starting antiretroviral treatment (ART), who are between 18 and 50 years old and have a mobile device, will be included in the study. The messages will consist of medical appointment reminders and adherence and motivational messages for a period of six months.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

HIV I Infection

Clinical Trial Details

NCT number	NCT05187741
Study type	Interventional
Source	Hospital Civil de Guadalajara
Contact
Status	Completed
Phase	N/A
Start date	April 1, 2022
Completion date	November 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04585737` - Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF	Phase 4
Not yet recruiting	`NCT06282783` - Studying Topiramate for Re-Activating the HIV-1 Reservoir	Phase 1/Phase 2
Not yet recruiting	`NCT03622177` - Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection
Recruiting	`NCT05854381` - To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV	Phase 1
Enrolling by invitation	`NCT05071378` - Leveraging Family-Based Assets for Black MSM In House Ball Communities	N/A
Completed	`NCT05421806` - A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/
Completed	`NCT04568395` - Acute Effects of TCIG vs ECIG in PLWH	N/A
Recruiting	`NCT04887675` - Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI	N/A
Recruiting	`NCT04820933` - Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV	Early Phase 1
Completed	`NCT03584048` - Charlotte Retention in Care Study
Recruiting	`NCT06005610` - Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy	Phase 2
Recruiting	`NCT05947890` - Evaluating the Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living With and Without HIV in South Africa	Phase 2
Recruiting	`NCT05187429` - Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy	Phase 1/Phase 2
Active, not recruiting	`NCT05601128` - A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA	Phase 3
Completed	`NCT04675255` - Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism	N/A
Recruiting	`NCT05110963` - Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments	N/A
Completed	`NCT03986099` - Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ART	N/A
Completed	`NCT04971343` - Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol
Completed	`NCT04725877` - VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers	Phase 1
Recruiting	`NCT04618198` - Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa	Phase 3